Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Bls 1 frá 43 niðurstöður
N-substituted-(Dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
Tumor necrosis factor alpha (TNF-.alpha.), also known as cachectin, is a 17 kDa protein produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes, endothelial cells, smooth muscle cells, and some transformed cells. A large number of
Purine derivatives and suppressants for inflammatory diseases
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
This invention relates to novel purine derivatives and pharmaceutical compositions containing thereof. The pharmaceutical compositions containing novel purine derivatives of the present invention are useful as suppressants for inflammatory diseases (anti-inflammatory drugs),
Anti-inflammatory substituted 9H-8-oxo-pyrimido[2,1-f]purine-2,4-diones
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The present invention relates to substituted 9H-8-oxo-pyrimido[2,1-f]purine-2,4-diones and tautomers thereof. These compounds are useful as anti-inflammatory agents for treating inflammatory conditions such as arthritis, spondylitis, and tendonitis in mammals.
In a composition of matter aspect, the
Anti-inflammatory and anti-allergic substituted-2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]-purine-4,8(1H,9H)-dio nes
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF INVENTION
The present invention relates to substituted 2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]purine-4,8(1H, 9H)-diones and tautomers thereof. These compounds are useful as anti-inflammatory agents for treating inflammatory conditions such as arthritis, spondylitis, and tendonitis in
Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
Tumor necrosis factor alpha (TNF-.alpha.), also known as cachectin, is a 17 kDa protein produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes, endothelial cells, smooth muscle cells, and some transformed cells. A large number of
2,6-Di (substitutedamino) purine ribonucleoside analogues and administration to treat respiratory inflammation
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The present invention relates to therapeutically active 2,6-diaminopurine-.beta.-D-ribofuranuronamide derivatives, processes for the manufacture of said compounds, pharmaceutical formulations containing said compounds and the use of said compounds in chemotherapy. In particular, we have found a
Purine derivatives and medicinal use thereof
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention relates to novel purine derivatives or pharmaceutically acceptable salts thereof and their application as medicines. The medicine comprising a purine derivative or a pharmaceutically acceptable salt thereof of the present invention as an active ingredient
Purine Derivatives and methods of use thereof
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
1. FIELD OF THE INVENTION
The invention relates to Purine Derivatives; compositions comprising an effective amount of a Purine Derivative; and methods for treating or preventing an ischemic condition, reperfusion injury, a cellular proliferative disorder, a cardiovascular disease, a neurological
Purine derivatives
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
This invention relates to purine derivatives, to processes for their preparation, to compositions containing them and to their use.
More particularly, the present invention relates to the use of purine derivatives in the treatment of a variety of viral infections and
Purine derivatives and methods of use thereof
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
1. FIELD OF THE INVENTION
The invention relates to Purine Derivatives; compositions comprising an effective amount of a Purine Derivative; and methods for treating or preventing an ischemic condition, reperfusion injury, a cellular proliferative disorder, a cardiovascular disease, a neurological
Purine and imidazopyridine derivatives for immunosuppression
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The invention relates to purine and imidazopyridine derivatives useful as immunosuppressants.
BACKGROUND OF THE INVENTION
Immunosuppression is an important clinical approach in treating autoimmune disease and in preventing organ and tissue rejection. The clinically available
Purine derivatives as modulators of TNF activity
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
This application is the US national phase under 35 U.S.C. .sctn. 371 of international application PCT/EP2014/076843, filed Dec. 8, 2014, which claims priority to GB application 1321737.7, filed Dec. 9, 2013.
The present invention relates to a class of fused imidazole derivatives, and to their use in
Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
This invention relates to novel substituted 6-(2-hydroxybenzylamino)purine derivatives, to their activity as polyspecific inhibitors of cyclin-dependent kinases 2, 5, 7, and 9 and to their use as medicaments.
BACKGROUND ART
The cyclin-dependent kinases (CDKs) are heterodimeric
6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD
The invention relates to 6,9-disubstituted purine derivatives as well as their use as, or in, cosmetics and/or cosmetic preparations.
BACKGROUND ART
In recent years, 6-substituted aminopurines have assumed considerable biochemical significance. Some compounds of this type promote
8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The invention relates to 8-substituted 2-(benzimidazolyl)purine derivatives and 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purine derivatives useful as immunosuppressants.
BACKGROUND OF THE INVENTION
Immunosuppression is an important clinical approach in treating autoimmune
Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum
- Virkar á 55 tungumálum
- Jurtalækningar studdir af vísindum
- Jurtaviðurkenning eftir ímynd
- Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
- Lestu vísindarit sem tengjast leit þinni
- Leitaðu að lækningajurtum eftir áhrifum þeirra
- Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum
Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum
